Get started
Gilead Sciences, Inc. 2.95% 01-MAR-2027Gilead Sciences, Inc. 2.95% 01-MAR-2027Gilead Sciences, Inc. 2.95% 01-MAR-2027

Gilead Sciences, Inc. 2.95% 01-MAR-2027

No trades
See on Supercharts
OverviewChartAnalysisNews

US375558BM4 chart



Key terms


Outstanding amount
‪1.25 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
2.95% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
4.06%
Maturity date
Mar 1, 2027
Term to maturity
1 year

About Gilead Sciences, Inc. 2.95% 01-MAR-2027


Issuer
Gilead Sciences, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
gilead.com
Issue date
Sep 20, 2016
ISIN
US375558BM47
FIGI
BBG00DSZ4R54
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

See how Gilead Sciences, Inc. is moving with its highest-yielding bonds.

US375558BM4 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

US375558BM4 news